The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Genetic Determinants of Resistance to Fusidic Acid among Clinical Bacteremia Isolates of Staphylococcus aureus
Abstract
Resistance to fusidic acid in Staphylococcus aureus is caused by mutation of the elongation factor G (EF-G) drug target (FusA class) or by expression of a protein that protects the drug target (FusB and FusC classes). Recently, two novel genetic classes of small-colony variants (SCVs) were identified among fusidic acid-resistant mutants selected in vitro (FusA-SCV and FusE classes). We analyzed a phylogenetically diverse collection of fusidic acid-resistant bacteremia isolates to determine which resistance classes were prevalent and whether these were associated with particular phylogenetic lineages. Each isolate was shown by DNA sequencing and plasmid curing to carry only one determinant of fusidic acid resistance, with approximately equal frequencies of the FusA, FusB, and FusC genetic classes. The FusA class (mutations in fusA ) were distributed among different phylogenetic types. Two distinct variants of the FusC class (chromosomal fusC gene) were identified, and FusC was also distributed among different phylogenetic types. In contrast, the FusB class (carrying fusB on a plasmid) was found in closely related types. No FusE-class mutants (carrying mutations in rplF ) were found. However, one FusA-class isolate had multiple mutations in the fusA gene, including one altering a codon associated with the FusA-SCV class. SCVs are frequently unstable and may undergo compensatory evolution to a normal growth phenotype after their initial occurrence. Accordingly, this normal-growth isolate might have evolved from a fusidic acid-resistant SCV. We conclude that at least three different resistance classes are prevalent among fusidic acid-resistant bacteremia isolates of S. aureus .
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Active protection of EF-G is caused in S. aureus by FusB and FusC proteins encoded by fusB and fusC genes.”
From Molecular Mechanisms of Drug Resistance in Staphylococcus aureus (2022) · cites this paper as [169]
In the citing paper
“The first mechanism is associated with mutations in the fusA or fusA-SCV genes encoding the elongation factor (EF-G). Therefore, conditioned resistance to fusidic acid is referred to as the FusA phenotype [169].”
From Molecular Mechanisms of Drug Resistance in Staphylococcus aureus (2022) · cites this paper as [169]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Proctor, R. A., von Eiff, C., Kahl, B. C., Becker, K., McNamara, P., Herrmann, M., & Peters, G. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1384 · Cited by 1,175
Persistent and Relapsing Infections Associated with Small-Colony Variants of Staphylococcus aureus
Proctor, R. A., van Langevelde, P., Kristjansson, M., Maslow, J. N., & Arbeit, R. D. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.1.95 · Cited by 437
von Eiff, C., Heilmann, C., Proctor, R. A., Woltz, C., Peters, G., & Götz, F. (1997) · Journal of Bacteriology · doi:10.1128/jb.179.15.4706-4712.1997 · Cited by 310 · cited 1×
“This distribution of SCVs is probably a consequence of their ability to persist intracellularly and thus to be shielded from the host immune response (2, 38, 40).”
BackgroundBalwit, J. M., Langevelde, P. V., Vann, J. M., & Proctor, R. A. (1994) · Journal of Infectious Diseases · doi:10.1093/infdis/170.4.1033 · Cited by 237
Research works printed but not linked: 40
- 10.1016/S0924-8579(98)00077-6 · DOI
- 10.1126/science.289.5481.905 · DOI · Paper page
- 10.1038/nature04616 · DOI · Paper page
- 10.1046/j.1365-2958.2003.03307.x · DOI
- 10.1126/science.287.5457.1479 · DOI · Paper page
- 10.1016/0006-291X(69)90934-6 · DOI · Paper page
- 10.1099/00221287-96-2-229 · DOI
- Falagas, M. E., and P. Kopterides. 2007. Old antibiotics for infections in critically ill patients. Curr. Opin. Crit. Care13:592-597. · DOI
- 10.2144/00296bm04 · doi:10.2144/00296bm04
- 10.1073/pnas.0402521101 · DOI · Paper page
- 10.1006/jmbi.1996.0259 · DOI
- 10.1128/JCM.41.9.4424-4427.2003 · DOI · Paper page
- 10.1128/JCM.42.2.792-799.2004 · DOI · Paper page
- Lacey, R. W., and J. Grinsted. 1972. Linkage of fusidic acid resistance to the penicillinase plasmid in Staphylococcus aureus. J. Gen. Microbiol.73:501-508. · doi:10.1099/00221287-73-3-501
- 10.1099/00222615-7-1-1 · DOI
- 10.1006/jmbi.2000.4168 · DOI
- 10.1016/j.tim.2004.06.004 · DOI · Paper page
- 10.1111/j.1365-2958.2004.04076.x · DOI · Paper page
- 10.1093/jac/dkn071 · doi:10.1093/jac/dkn071
- 10.1186/1471-2180-7-98 · DOI · Paper page
- 10.1046/j.1365-2958.2001.02389.x · DOI · Paper page
- 10.1128/AAC.00328-07 · DOI
- 10.1093/jac/dkf153 · DOI
- 10.1111/j.1365-2958.2005.04971.x · DOI
- 10.1128/AAC.48.9.3594-3597.2004 · DOI
- 10.1128/JCM.01984-06 · DOI
- 10.1128/AAC.01542-06 · DOI
- Pan, A., S. Lorenzotti, and A. Zoncada. 2008. Registered and investigational drugs for the treatment of methicillin-resistant Staphylococcus aureus infection. Recent Pat. Antiinfect. Drug Discov.3:10-33. · DOI
- 10.1016/S0022-2836(05)80167-6 · DOI
- 10.1111/j.1574-6968.1992.tb05302.x · DOI · Paper page
- 10.1128/JCM.37.11.3556-3563.1999 · DOI · Paper page
- 10.1111/j.1432-1033.1982.tb06859.x · DOI
- 10.1016/S0924-8579(98)00074-0 · doi:10.1016/s0924-8579(98)00074-0
- Trampuz, A., and W. Zimmerli. 2006. Antimicrobial agents in orthopaedic surgery: prophylaxis and treatment. Drugs66:1089-1105. · DOI · Paper page
- 10.1086/320519 · DOI · Paper page
- 10.1086/516962 · DOI · Paper page
- von Eiff, C., R. A. Proctor, and G. Peters. 2000. Small colony variants of Staphylococci: a link to persistent infections. Berl. Munch. Tieraerztl. Wochenschr.113:321-325.
- 10.1016/S0924-8579(98)00070-3 · DOI
- 10.1016/S0924-8579(98)00105-8 · doi:10.1016/s0924-8579(98)00105-8
- 10.1021/bi00679a025 · DOI
Cited by
Mobile Genetic Elements Associated with Antimicrobial Resistance
Partridge, S. R., Kwong, S. M., Firth, N., & Jensen, S. O. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00088-17 · Cited by 2,751
Antibiotic resistance and its cost: is it possible to reverse resistance?
Andersson, D. I., & Hughes, D. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2319 · Cited by 2,294
Self-citationMolecular Mechanisms of Drug Resistance in Staphylococcus aureus
Mlynarczyk-Bonikowska, B., Kowalewski, C., Krolak-Ulinska, A., & Marusza, W. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158088 · Cited by 412
Current and Emerging Topical Antibacterials and Antiseptics: Agents, Action, and Resistance Patterns
Williamson, D. A., Carter, G. P., & Howden, B. P. (2017) · Clinical Microbiology Reviews · doi:10.1128/cmr.00112-16 · Cited by 374
Small colony variants (SCVs) of Staphylococcus aureus – A bacterial survival strategy
Kahl, B. C. (2014) · Infection, Genetics and Evolution · doi:10.1016/j.meegid.2013.05.016 · Cited by 118
Metadata
- Authors
- Lannergård, J., Norström, T., & Hughes, D.
- Affiliations
- Microbiology Programme, Department of Cell and Molecular Biology, Box 596, Biomedical Center, Uppsala University, S-75124 Uppsala, Sweden
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2009-05
- Volume
- 53
- Issue
- 5
- Pages
- 2059-2065
- ISSN
- 0066-4804
- 1098-6596
- Cited by
- 54
- References
- 4
- Language
- en
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.